Nektar Therapeutics

NKTR Mid Cap

Healthcare · Biotechnology

Aktualisiert: Apr 5, 2026, 17:43 UTC

$76.99

+1.69% heute

52W: $6.45 – $78.81

52W Low: $6.45 Position: 97.5% 52W High: $78.81

🔗 Broker vergleichen

Kennzahlen

P/E Ratio

—

Kurs/Gewinn-Verhältnis

Forward P/E

—

Erwartetes KGV

P/S Ratio

39.99x

Kurs/Umsatz-Verhältnis

EV/EBITDA

—

Unternehmenswert/EBITDA

Dividendenrendite

—

Jährl. Dividendenrendite

Market Cap

$2.2B

Marktkapitalisierung

Umsatzwachstum

-25.3%

YoY Umsatzwachstum

Gewinnmarge

-297.07%

Nettomarge

ROE

-217.94%

Eigenkapitalrendite

Beta

1.18

Marktsensitivität

Short Interest

12.96%

% der Aktien leerverkauft

Ø Volumen

1,125,772

Durchschn. Tagesvolumen

Bewertungs-Analyse

Signal

N/A

vs. S&P 500 Ø KGV (24.7x)

Analysten-Konsens

Starker Kauf

8 Analysten

Ø Kursziel

$128.12

+66.42% Upside

Kursziel Spanne

$70.00 – $165.00

Über das Unternehmen

Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in the field of immunotherapy in the United States and internationally. It develops rezpegaldesleukin, which is in Phase 2b to treat underlying immune system imbalance in people with autoimmune disorders and inflammatory diseases; NKTR-0165 to treat ulcerative colitis, vitiligo, and multiple sclerosis; NKTR-0166 to treat autoimmune disease; NKTR-422 to treat fibrotic diseases; and NKTR-255 to treat solid tumors and large b-cell lymphoma. It has collaboration agreements with Takeda Pharmaceutical Company Ltd.; AstraZeneca AB; UCB Pharma; F. Hoffmann-La Roche Ltd; Bausch Health Companies Inc.; Pfizer Inc.; UCB Pharma (Biogen); Bristol-Myers Squibb Company; and Merck KGaA. The company was incorpo

Sektor: Healthcare Branche: Biotechnology Land: United States Mitarbeiter: 63 Börse: NCM

Trading-Daten

50-Day MA: $62.26

200-Day MA: $47.48

Volumen: 543,429

Ø Volumen: 1,125,772

Short Ratio: 3.55

Kurs/Buchwert: 17.47x

Verschuldung/EK: 165.76x

Free Cash Flow: $-108,228,872

Wo kann ich Nektar Therapeutics kaufen?

Vergleiche die besten Broker — niedrige Gebühren, seriöse Anbieter, reguliert.

Broker vergleichen →